Evaluation of Standardized Usage of Oral Antidiabetic Agents in Inpatients' Prescriptions / 中国药师
China Pharmacist
;
(12): 125-128, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-705468
ABSTRACT
Objective:
To evaluate the standardized usage of oral antidiabetic agents in inpatients to provide reference for the pre -scription standardization .Methods:
A retrospective study was used to evaluate the prescriptions of oral antidiabetic agents in inpatients during January and March in 2017 , and statistical analysis was conducted on drug usage and standardization evaluation .Results:
There were 886 medication plans including 4,397 prescriptions, which involved in 13 kinds of antidiabetic agents .Metformin and acarbose a-gents were used most frequently .The non-standardization rate was 70.54%with 66.03%unlabeled accurate time for oral administra-tion and 4.51% labeled wrong time for oral administration .Twelve antidiabetic agents existed non-standardized applications ( >50%) .Conclusion:
The main problem in the non-standardized usage of antidiabetic agents is leaving the special time for oral adminis -tration of antidiabetic agents out of account , which not only affect the best efficacy , but also reduce patients ' compliance .It' s neces-sary to standardize the prescriptions of antidiabetic agents to improve the standardization of medication therapy .
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio observacional
Idioma:
Chino
Revista:
China Pharmacist
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS